Biostar Pharmaceuticals, Inc. Other Deferred Cost, Amortization Expense (Deprecated 2013-01-31)
Biostar Pharmaceuticals, Inc. reported Other Deferred Cost, Amortization Expense (Deprecated 2013-01-31) of $796.00 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherDeferredCostAmortizationExpense · last filed 2013-05-15
- Biostar Pharmaceuticals, Inc. other deferred cost, amortization expense (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $796.00K, a 0.62% increase year-over-year.
- Biostar Pharmaceuticals, Inc. other deferred cost, amortization expense (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $791.13K.
- Biostar Pharmaceuticals, Inc. other deferred cost, amortization expense (deprecated 2013-01-31) for fiscal 2012 was $4.48M, a 91.87% increase from fiscal 2011.
- Biostar Pharmaceuticals, Inc. other deferred cost, amortization expense (deprecated 2013-01-31) for fiscal 2011 was $2.33M.
| Period end | Other Deferred Cost, Amortization Expense (Deprecated 2013-01-31) 3 month | Other Deferred Cost, Amortization Expense (Deprecated 2013-01-31) 12 month |
|---|---|---|
| 2013-03-31 | $796.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $4.48M 10-K · filed 2013-04-15 | |
| 2012-03-31 | $791.13K 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $2.33M 10-K · filed 2013-04-15 |